New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 8, 2012
06:38 EDTMRNA, MONMarina Biotech announces worldwide exclusive licensing agreement with Monsanto
Marina Biotech (MRNA) announced that it has entered into an exclusive licensing agreement with Monsanto (MON) for Marina Biotech's delivery and chemistry technologies. Terms of the agreement were not disclosed.
News For MRNA;MON From The Last 14 Days
Check below for free stories on MRNA;MON the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 9, 2014
12:04 EDTMONU.S. corn exports projected to increase 125M bushels
Subscribe for More Information
April 3, 2014
10:00 EDTMONOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:36 EDTMONMonsanto management to meet with Deutsche Bank
Field trip to company headquarters to be held in St. Louis, MO on April 3 hosted by Deutsche Bank.
09:14 EDTMONOn The Fly: Pre-market Movers
Subscribe for More Information
07:21 EDTMONMonsanto upgraded to Overweight from Neutral at JPMorgan
Subscribe for More Information
06:37 EDTMONMonsanto upgraded to Overweight from Neutral at JPMorgan
April 2, 2014
12:33 EDTMONOn The Fly: Midday Wrap
Subscribe for More Information
10:23 EDTMONMonsanto says sees 'more aggressive' returns to shareholders
Subscribe for More Information
10:05 EDTMONMonsanto sees Q3 'somewhat' lower than last year
Subscribe for More Information
08:51 EDTMONMonsanto says 'confident' in FY growth despite headwinds
Subscribe for More Information
08:08 EDTMONMonsanto reports Q2 Corn seed and traits revenue $3.41B
Subscribe for More Information
08:06 EDTMONMonsanto backs FY14 free cash flow view $600M-$800M
The company reaffirmed free cash flow in the range of $600M-$800M for FY14. The free cash flow guidance is inclusive of the cash used for the company’s FY14 acquisition of The Climate Corporation and recent BioAg Alliance with Novozymes. The company expects net cash provided by operating activities to be $2.9B-$3.3B, and net cash required by investing activities to be approximately $2.3B-$2.5B for FY14, including capital expenditures and acquisition-related costs. For the first half of FY14, cash flow from operations was a source of approximately $1.8B, slightly lower than the same period last year. Net cash required by investing activities for the first half of FY14 was approximately $1.6B. Monsanto spent an additional $203M on share buybacks in the second quarter.
08:03 EDTMONMonsanto backs FY14 ongoing EPS view $5.00-$5.20, consensus $5.26
Subscribe for More Information
08:01 EDTMONMonsanto reports Q2 ongoing EPS $3.15, consensus $3.07
Reports Q2 revenue $5.83B, consensus $5.8B.
07:19 EDTMONMonsanto analysts expecting best ever quarter, WSJ says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use